JPRN-UMIN000036594已完成未知
Perioperative response of arginine vasopressin and aquaporin-2 in cardiac surgery - Perioperative AVP and AQP2 study
ippon Medical School0 个研究点目标入组 8 人开始时间: 2019年4月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
Median plasma arginine vasopressin levels significantly increased to 1.5,15.3*,2.2,1.7(pg/mL) preoperatively, on postoperative days 1, 4, and 7, respectively (*: p=0.0001). Similarly, levels of urine aquaporin-2 markedly increased in 3.4, 25.8**, 9.3, 5.4(ng/mL), respectively (**p=0.0004).
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •emergency cases or critical cases required management in ICU before surgery, hemodialysis cases
研究者
相似试验
已完成
不适用
Evaluation of plasma arginine vasopressin in hypertonic saline test in patients with diencephalohypophysial diseasesDiabetes insipidusJPRN-UMIN000020112Department of Endocrinology and Diabetes, Nagoya Graduate School of Medicine20
已完成
2 期
Early Use of Vasopressin in Post-Fontan ManagementCirculatory Perfusion DisorderSingle-ventricleCongenital Heart DiseaseNCT03088345Medical College of Wisconsin20
进行中（未招募）
1 期
Arginin Vasopressin im fortgeschrittenen vasodilatorischen Schock: Ein Dosisvergleich 2 vs. 4 IU/h5. Einschlusskriterien5.1. Patienten mit vasodilatorischem Schock aufgrund:a) Sepsis [Definitionen gemäss den Empfehlungen der ACCP/SCCM (12)]b) SIRS [Definitionen gemäss den Empfehlungen der ACCP/SCCM (12)]c) SIRS nach herzchirurgischen Eingriffen mit Verwendung der Herzlungen-Maschine5.2. Hypotonie (MAP <60 mmHg) trotz5.3. Noradrenalinbedarf >0,6 µg/kg/min zur Erreichung eines MAP >60 mmHgMedDRA version: 9.1Level: LLTClassification code 10021118Term: HypotoniaEUCTR2007-005010-40-ATniv.-Prof. Dr. Volker Wenzel50
招募中
不适用
Registry of Patients in Shock Treated With VasopressinVasopressin Causing Adverse Effects in Therapeutic UseShockVasopressor Adverse ReactionVasopressin DeficiencyNCT06422975Hospital Universitario 12 de Octubre500
已完成
不适用
Evaluation of Vasopressin in the Vessels of Ovarian NeoplasmsOvarian NeoplasmsNCT00160472United States Department of Defense110